FEATURES OF DIAGNOSTICS AND TREATMENT OF VEGENER'S GRANULOMATOSIS 

Levina Tat'yana Mikhaylovna, Candidate of medical sciences, associate professor, sub-department of hospital therapy, Medical Institute, National Research Mordovia State University (68 Bolshevistskaya street, Saransk, Russia), E-mail: tmlevina@mail.ru
Romanov Mikhail Dmitrievich, Doctor of medical sciences, professor, sub-departmet of hospital surgery, Medical Institute, National Research Mordovia State University (68 Bolshevistskaya street, Saransk, Russia), E-mail: mdromanov@yandex.ru
Kireeva Ekaterina Mikhaylovna, Candidate of medical sciences, associate professor, sub-department of hospital surgery, Medical Institute, National Research Mordovia State University (68 Bolshevistskaya street, Saransk, Russia), E-mail: emkireeva@yandex.ru 

616.13-002:616-006.443 

10.21685/2072-3032-2019-1-2 

Background. The aim of the study was to study the features of early diagnosis and treatment of Wegener's granulomatosis (granulomatosis with polyangiitis).
Materials and methods. The analysis of the features of diagnosis and treatment of Wegener's granulomatosis (WH) based on the materials of publications and own clinical observation of a limited variant of this disease, the harbinger of which was the torpid course of recurrent rhinitis with the formation of "crusts with hemorrhages" without increasing body temperature. The development of pneumonia with abscess formation compared to other minimal signs (sinusitis, otitis media, pain in the joints) allowed to suspect the presence of Wegener's granulomatosis and adequate complex therapy, which allowed to stop the processes of destruction and inflammation, and led to a stable remission of the disease.
Results and conclusions. An analysis of the features of the diagnosis and treatment of Wegener's granulomatosis based on publications and in the presented clinical observation demonstrates the need for an integrated approach in assessing the totality of early clinical signs (sinusitis, otitis, and upper respiratory tract pathology, etc.) characteristic of this disease. Early assignment of the starting complex (including immunosuppressive) ex juvantibus therapy aimed at preventing the progression of irreversible organ changes, despite its undesirable side effects, if at least two diagnostic criteria for WH are present, it will prevent further dramatic development of events and improve clinical results and prognosis. 

Wegener's granulomatosis, early diagnosis, immunosuppressive therapy, cyclophosphamide, rituximab 

1. Greco A., Marinelli C., Fusconi M., Macri G. F., Gallo A., De Virgilio A., Zambetti1 G. and de Vincentiis M. International Journal of Immunopathology and Pharmacology. 2016, vol. 29, no. 2, pp. 151–159. DOI 10.1177/0394632015617063.
2. Baranov A. A., Alekseeva E. I., Valieva S. I., Bzarova T. M., Lyskina G. A., Chasnyk V. G., Kostik M. M. Klinicheskie rekomendatsii MZ RF [Clinical recommendations of the Ministry of Health of the Russian Federation]. Moscow: MZ RF, 2017, 73 p. [In Russian]
3. Leavitt R. Y., Fauci A. S., Bloch D. A., Michel B. A., Hunder G. G., Arend W. P., Calabrese L. H., Fries J. F., Lie J. T., Lightfoot R. W., Masi A. T., Mcshane D. J., Mills J. A., Stevens M. B., Wallace S. L. and Zvaifler N. J. Arthr. Rheum. 1990, vol. 33, pp. 1101–1107.
4. Rumyantsev A. G. Voprosy gematologii/onkologii i immunopatologii v pediatrii [Hematology/ oncology and immunopathology in pediatrics]. 2016, no. 2, pp. 6–14. DOI 10.20953/1726-1708-2016-2-5-13. [In Russian]
5. Beketova T. V. Nauchno-prakticheskaya revmatologiya [Scientific and practical rheumatology]. 2017, vol. 55, no. 1, pp. 12–16. [In Russian]
6. Yates M., Watts R. A., Bajema I. M., Cid M. C., Crestani B., Hauser T., Hellmich B., Holle J. U., Laudien M., Little M. A., Luqmani R. A., Mahr A., Merkel P. A., Mills J., Mooney J., Segelmark M., Tesar V., Westman K., Vaglio A., Yalçindag N., Jayne D. R. and Mukhtyar C. Ann. Rheum. Dis. 2016, vol. 75, pp. 1583–1594. DOI 10.1136/annrheumdis-2016-209133 originally published online June 23, 2016.
7. Moiseev S. V., Novikov P. I., Meshkov A. D., Ivanitskiy L. V. Klinicheskaya farmakologiya i terapiya [Clinical pharmacy and therapy]. 2014, vol. 23, no. 1, pp. 44–50. [In Russian]
8. Krut'ko V. S., Poteyko P. I., Khodosh E. M. Novosti meditsiny i farmatsii. Pul'monologiya. Allergologiya. Antimikrobnaya terapiya [News of medicine and pharmacy. Pulmonology. Allergology. Antimicrobial therapy]. 2015, no. 1 (530), pp. 63–72. [In Russian]
9. Khodosh, E. M., Krut'ko V. S., Efremova O. A. Nauchnye vedomosti Belgorodskogo gosudar-stvennogo universiteta. Ser.: Meditsina. Farmatsiya [Scientific bulletin of Belgorod State University. Series: Medicine. Pharmacy]. 2017, no. 19 (268), iss. 39, pp. 40–53. [In Russian]
10. Lutalo P. M., D’Cruz D. P. J. Autoimmun. 2014, vol. 48-49, pp. 94–98.
11. Westman K., Flossmann O. and Gregorini G. Nephrol. Dial. Transplant. 2015, vol. 30, pp. 60–66. DOI 10.1093/ndt/gfu392.